Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-060826
Filing Date
2005-12-14
Accepted
2005-12-14 17:09:46
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a05-21639_110k.htm 10-K 2758741
2 CONSENTS OF EXPERTS AND COUNSEL a05-21639_1ex23d1.htm EX-23.1 4918
3 302 CERTIFICATION a05-21639_1ex31d1.htm EX-31.1 13780
4 302 CERTIFICATION a05-21639_1ex31d2.htm EX-31.2 13703
5 906 CERTIFICATION a05-21639_1ex32.htm EX-32 7904
  Complete submission text file 0001104659-05-060826.txt   2800501
Mailing Address 8899 UNIVERSITY CENTER LANE STE 400 SAN DIEGO CA 92122
Business Address 8899 UNIVERSITY CTR LANE STE 400 SAN DIEGO CA 92122 8584534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 051264541
SIC: 2833 Medicinal Chemicals & Botanical Products